Literature DB >> 9436291

Evaluation of 99mtechnetium-radiopharmaceutical binding to blood elements using different trichloroacetic acid concentrations.

R S Freitas1, B Gutfilen, L M da Fonseca, M Bernardo-Filho.   

Abstract

Secure determination of the binding of 99mTc-radiopharmaceuticals to plasma (P) and blood cell (BC) constituents can help to understand the biodistribution of radiophamaceuticals. The reported precipitation studies of blood with radiopharmaceuticals have shown that the results can not be easily compared between studies. We decided to determine the "gold standard" concentration of trichloroacetic acid (TCA) to evaluate the binding to blood elements for several radiopharmaceuticals used in routine nuclear medicine. We have studied phytic (99mTc-PHY), diethylenetriaminepentaacetic (99mTc-DTPA), glucoheptonic (99mTc-GHA) and dimercaptosuccinic (99mTc-DMSA) acids. Blood was incubated with radiopharmaceuticals, centrifuged and P and BC separated. Samples of P and BC were also precipitated with TCA concentrations (20.0, 10.0, 5.0, 1.0, 0.5 and 0.1 percent) and soluble (SF) and insoluble fractions (IF) were isolated. The percent radioactivity (percent rad) in IF-P depends on TCA concentration. It varied from 36.4 to 65.0 (99mTc-PHY), from 17.9 to 32.0 (99mTc-DTPA), from 11.5 to 38.8 (99mTc-GHA) and from 52.8 to 66.2 (99mTc-DMSA). The results for the binding of 99mTc-PHY to IF-P show that there was no differences in the percent rad when TCA concentrations of 0.1 to 1.0 percent were used. For 99mTc-DTPA, 5.0 percent is the best TCA concentration. For 99mTc-GHA, low values of percent rad bound to IF-P is found with TCA concentrations of 0.1, 0.5 and 1.0. Interestingly, with 99mTc-DMSA, high values of bound radioactivity are not dependent on TCA concentrations (0.1 to 10.0). Radioactivity in IF-BC depends on TCA concentration and it varied for 99mTc-PHY (80.1 to 54.1) and for 99mTc-GHA (85.5 to 61.7). With 99mTc-DTPA and with 99mTc-DMSA the percent rad in IF-BC seems independent of TCA concentration. We suggest that the evaluation of the binding of the various 99mTc-radiopharmaceuticals to blood constituents, using only one TCA concentration, should be avoided.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9436291      PMCID: PMC2589038     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  7 in total

Review 1.  Bone seeking pharmaceuticals.

Authors:  C L de Ligny; W J Gelsema; T G Tji; Y M Huigen; H A Vink
Journal:  Int J Rad Appl Instrum B       Date:  1990

2.  Interaction of 99mTc-radiopharmaceuticals with transport proteins in human blood.

Authors:  N Vanlić-Razumenić; J Joksimović; B Ristić; M Tomić; S Beatovć; B Ajdinović
Journal:  Nucl Med Biol       Date:  1993-04       Impact factor: 2.408

Review 3.  Drug interactions with radiopharmaceuticals.

Authors:  S Hesslewood; E Leung
Journal:  Eur J Nucl Med       Date:  1994-04

4.  Physico-chemical study of the radiopharmaceuticals 99mTc-DMSA, 99mTc-EDTA and 99mTc-DTPA interaction with plasmatic proteins.

Authors:  R Garcia Domenech; O Abril Mendez; J Galvez Alvarez; A Farga Marti
Journal:  Int J Rad Appl Instrum A       Date:  1989

5.  Protein-binding and urinary excretion of 99mTc(Sn)-MDP and 99mTc-MDP.

Authors:  T J Savelkoul; J J van Ginkel; R J Grouls; S J Oldenburg; S A Duursma
Journal:  Int J Nucl Med Biol       Date:  1985

6.  Effect of different anticoagulants on the labelling of red blood cells and plasma proteins with 99Tcm.

Authors:  M Bernardo-Filho; B Gutfilen; O de S Maciel
Journal:  Nucl Med Commun       Date:  1994-09       Impact factor: 1.690

7.  Quality control of technetium-99m DTPA: correlation of analytic tests with in vivo protein binding in man.

Authors:  C D Russell; K Rowell; J W Scott
Journal:  J Nucl Med       Date:  1986-04       Impact factor: 10.057

  7 in total
  2 in total

1.  Urinary C-megalin for screening of renal scarring in children after febrile urinary tract infection.

Authors:  Sohsaku Yamanouchi; Takahisa Kimata; Jiro Kino; Tetsuya Kitao; Chikushi Suruda; Shoji Tsuji; Hiroyuki Kurosawa; Yoshiaki Hirayama; Akihiko Saito; Kazunari Kaneko
Journal:  Pediatr Res       Date:  2017-12-06       Impact factor: 3.756

2.  Evaluation of technetium-99m decay on Escherichia coli inactivation: effects of physical or chemical agents.

Authors:  C R Silva; J O Valsa; M S Caniné; A Caldeira-de-Araújo; M Bernardo-Filho
Journal:  Yale J Biol Med       Date:  1998 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.